opiate dependence
opiate dependence
Explore linked clinical trials. Standard reference: MONDO:0005530338 results · Page 1 of 14
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Supporting Treatment for Opioids and Recovery Capital (STORC) - R61 Phase | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2026-10-09 | NCT07787039 | |
| Cannabis and Opioid Use Disorder, Study 2 | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, cannabis dependence, opiate dependence, psychiatric disorder, substance-related disorder | Not yet recruiting | Phase 1 | 2026-10-09 | NCT07661446 | |
| Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy Clinic | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Phase 4 | 2026-10-09 | NCT07176351 | |
| MedSMA℞T Mobile ED | Chemically-Induced Disorders, Narcotic-Related Disorders, opiate dependence, psychiatric disorder, substance-related disorder | Not yet recruiting | Not applicable | 2026-10-09 | NCT06848504 | |
| The Effect of Light Intervention on Recovery in Individuals With Opioid Use Disorder (OUD) | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2026-10-09 | NCT06832007 | |
| Adapting and Implementing a Chronic Disease Self-Management Program for Primary Care Patients With Opioid Use Disorder and Serious Mental Illness. | Chemically-Induced Disorders, Narcotic-Related Disorders, opiate dependence, psychiatric disorder, substance-related disorder | Not yet recruiting | Not applicable | 2026-10-08 | NCT07865078 | |
| Reducing Opioid Use After Upper Extremity Surgery: Testing Lower Prescriptions and Pill Quantity | Chemically-Induced Disorders, Narcotic-Related Disorders, Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and Symptoms, opiate dependence, psychiatric disorder, substance-related disorder | Enrolling by invitation | Phase 4 | 2026-10-08 | NCT07750639 | |
| Chicago Data-driven Opioid Use Disorder Screening, Engagement, Treatment and Planning System | Chemically-Induced Disorders, Narcotic-Related Disorders, opiate dependence, psychiatric disorder, substance-related disorder | Not yet recruiting | Not applicable | 2026-10-08 | NCT07498322 | |
| Towards Testing the Effectiveness of Recovery Community Centers (RCCs) | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Active, not recruiting | Not applicable | 2026-10-08 | NCT07010978 | |
| Measurement Based Care in Opioid Treatment Programs | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Enrolling by invitation | Not applicable | 2026-10-08 | NCT06965010 | |
| Clinician Practice Companion to Address Youth Substance Use | Chemically-Induced Disorders, Drug Misuse, Drug Overdose, Narcotic-Related Disorders, Opioid Use Disorder, Prescription Drug Misuse, Substance Use, cannabis dependence, opiate dependence, psychiatric disorder, substance-related disorder | Not yet recruiting | Not applicable | 2026-10-07 | NCT07725289 | |
| A Study of Brenipatide in Participants With Opioid Use Disorder | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Phase 2 | 2026-10-07 | NCT07420283 | |
| Machine-Learning Prediction and Reducing Overdoses With EHR Nudges | Chemically-Induced Disorders, Drug Misuse, Drug Overdose, Narcotic-Related Disorders, Opiate Overdose, Opioid Use Disorder, Prescription Drug Misuse, opiate dependence, psychiatric disorder, substance-related disorder | Active, not recruiting | Not applicable | 2026-10-06 | NCT06806163 | |
| Safety, Tolerability, and Pharmacokinetics of MCAM in Healthy Adult Participants | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Not yet recruiting | Early phase 1 | 2026-10-05 | NCT07602335 | |
| Cannabidiol in Opioid Use Disorder and Chronic Pain | Chemically-Induced Disorders, Chronic Pain, Narcotic-Related Disorders, Neurologic Manifestations, Opioid Use Disorder, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, opiate dependence, psychiatric disorder, substance-related disorder | Active, not recruiting | Early phase 1 | 2026-10-05 | NCT04587791 | |
| Characterization of CB1 Receptors Using [11-C]OMAR in Opioid Use Disorder | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Phase 1 | 2026-10-02 | NCT07800520 | |
| A Bundled Intervention to End Opioid Overdoses | Chemically-Induced Disorders, Disease Attributes, Drug Misuse, Drug Overdose, Emergencies, Narcotic-Related Disorders, Opiate Overdose, Opioid Use Disorder, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Prescription Drug Misuse, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Phase 4 | 2026-10-02 | NCT07485335 | |
| Mobile Platform for Optimizing Wellness and Engagement in Recovery | Alcohol Use Disorder, Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, alcohol-related disorders, opiate dependence, psychiatric disorder, substance-related disorder | Active, not recruiting | Not applicable | 2026-10-02 | NCT07178990 | |
| Outcome Inference in the Sensory Preconditioning Task in Opioid-Use Disorder | Chemically-Induced Disorders, Narcotic-Related Disorders, drug dependence, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Not stated | 2026-10-02 | NCT03745339 | |
| Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses | Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Narcotic-Related Disorders, Neoplasms by Histologic Type, Opioid Use Disorder, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2026-10-01 | NCT07631598 | |
| Real-World Evaluation of Compl-AI for Predicting Early Medication Dropout in Opioid Use Disorder Treatment | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Not yet recruiting | Not stated | 2026-10-01 | NCT07456930 | |
| Adjunctive Cannabidiol for Recovery From Opioid Study | Chemically-Induced Disorders, Narcotic-Related Disorders, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Phase 3 | 2026-10-01 | NCT06940674 | |
| Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD) | Chemically-Induced Disorders, Narcotic-Related Disorders, opiate dependence, psychiatric disorder, substance-related disorder | Active, not recruiting | Phase 2 | 2026-10-01 | NCT04464980 | |
| Measurement-Based Care to Support Buprenorphine-Naloxone Treatment in Outpatient Addiction Clinics | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Not yet recruiting | Not applicable | 2026-09-30 | NCT07839182 | |
| iSTEP-N 101b: Pharmacokinetics and Safety Study of Low- and High-Dose Naltrexone Implants vs Monthly Vivitrol in Healthy Volunteers | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Active, not recruiting | Phase 1 | 2026-09-30 | NCT07064564 |